Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 5-6, 1996, Pages 275-282

  Fujimoto, Jiro ^a   Ichigo, Satoshi ^a   Hori, Masashi ^a   Morishita, Shigeo ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTININ; ALPHA CATENIN; BETA CATENIN; DANAZOL; ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE; UVOMORULIN; VINCULIN;

ARTICLE; CELL ADHESION; CELL LINE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL;

ADENOCARCINOMA; ALPHA CATENIN; BETA CATENIN; CADHERINS; CELL ADHESION; CELL AGGREGATION; CYTOSKELETAL PROTEINS; DANAZOL; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; PROGESTERONE; PROGESTINS; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0029945486     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00281-2     Document Type: Article

References (34)

1. Folkman J.: Angiostatic steroids. Ann. Surg. 206 (1987) 374-383.
2. Fujimoto J., Fujita H., Hosoda S. and Okada H.: Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancers. Invasion and Metastasis 9 (1989) 209-215.
3. Fujimoto J., Hosoda S., Fujita H. and Okada H.: Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion and Metastasis 9 (1989) 269-277.
4. Jikihara H., Terada N., Yamamoto R., Nishikawa Y., Tanizawa O., Matsumoto K. and Terakawa N.: Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. Am. J. Obstet. Gynec. 167 (1992) 207-211.
5. Schatz F. and Lockwood C.: Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J. Clin. Endocr. Metab. 77 (1993) 621-625.
6. Takeichi M.: Functional correlation between cell adhesion properties and some cell surface proteins. J. Cell Biol. 75 (1977) 464-474.
7. Tsukita Sa., Oishi K., Akiyama T., Yamamoto T. and Tsukita Sh.: Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated. J. Cell Biol. 113 (1991) 867-879.
8. Takeichi M.: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451-1455.
9. Blasschuk O. W. and Farookhi R.: Estradiol stimulates cadherin expression in rat granulosa cells. Dev. Biol. 136 (1989) 564-567.
10. Choi Y. S., Sehgal R., McCrea P. and Gumbinder B.: A cadherin-like protein in eggs and cleaving embryos of Xenopus laevis is expressed in oocytes in response to progesterone. J. Cell Biol. 110 (1990) 1575-1582.
11. Nishida M., Kasahara K., Kaneko M. and Iwasaki H.: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta. Obstet. Gynec. Jpn. 37 (1985) 1103-1110.
12. Takeichi M. and Okada T. S.: Roles of magnesium and calcium ion in cell-to-substrate adhesion. Exp. Cell Res. 74 (1972) 51-60.
13. 2+ binding site of uvomorulin abolish the adhesive function. Cell 63 (1990) 1033-1038.
14. Urushihara H., Ozaki H. S. and Takeichi M.: Immunological detection of cell surface components related with aggregation of Chinese hamster and chick embryonic cells. Dev. Biol. 70 (1979) 206-216.
15. Matsuyoshi N., Hamaguchi M., Taniguchi S., Nagafuchi A., Tsukita S. and Takeichi M.: Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118 (1992) 703-714.
16. Chomczynski P. and Sacchi N.: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162 (1987) 156-159.
17. Bussemakers M. J. G., van Bokhoven A., Kemler M. R. and Schalken J. A.: Molecular cloning and characterization of human E-cadherin cDNA. Molec. Biol. Rep. 17 (1993) 123-128.
18. Arcari P., Martinelli R. and Salvatore F.: The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucl. Acids Res. 12 (1984) 9179-9189.
19. Shimoyama Y. and Hirohashi S.: Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 51 (1991) 2185-2192.
20. Shozaki H., Tahara H., Oka H., Miyata M., Kobayashi K., Tamura S., Iihara K., Doki Y., Hirano S., Takeichi M. and Mori T.: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Path. 139 (1991) 17-23.
21. Schipper J. H., Frixen U. H., Behrens J., Unger A. and Birchmeier W.: E-cadherin expression in squamous cell carcinoma of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51 (1991) 6328-6337.
22. Mattijssen V., Peters H. M., Schalkwijk L., Manni J. J., Hof-Grootenboer B. V., De Mulder P. H. M. and Ruiter D. J.: E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer 55 (1993) 580-585.
23. Umbas R., Scalken J. A., Aalders T. W., Carter B. S., Karthaus H. F. M., Schaafsma H. E., Debruyne M. J. and Isaacs W. B.: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52 (1992) 5104-5109.
24. Bringuier P. P., Umbas R., Schaafsma H. E., Karthaus H. F. M., Debruyne M. J. and Scalken J. A.: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53 (1993) 3241-3245.
25. Oda T., Kanai Y., Oyama T., Yoshiura K., Shimoyama Y., Birchmeier W., Sugimura T. and Hirohashi S.: E-cadherin gene mutation in human gastric carcinoma cell lines. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 1858-1862.
26. Risinger J. I., Berchuck A., Kohler M. and Boyd J.: Mutation of the E-cadherin gene in human gynecologic cancers. Nature Genet. 7 (1994) 98-102.
27. Behrens J., Mareel M. M., Van Roy F. M. and Birchmeier W.: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108 (1989) 2435-2447.
28. Vleminckx K., Vakaet L. Jr., Mareel M., Fiers W. and Van Roy F.: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66 (1991) 107-119.
29. Frixen U. H., Behrens J., Sachs M., Eberle G., Warda A., Lochner D. and Birchmeier W.: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113 (1991) 173-185.
30. Shinoyama Y., Nagafuchi A., Fukita S., Gotoh M., Takeichi M., Tsukita Sh. and Hirohashi S.: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 52 (1992) 5770-5774.
31. Oda T., Kanai Y., Shinoyama Y., Nagafuchi A., Tsukita Sh. and Hirohashi S.: Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem. Biophys. Res. Commun. 193 (1993) 897-904.
32. Hirano S., Kimoto N., Shinoyama Y., Hirohashi S. and Takeichi M.: Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70 (1992) 293-301.
33. Kanai Y., Shiniyama Y., Oda T. and Hirohashi S.: Abnormalities of cell adhesion molecules in multistage carcinogenesis: Gann Monogr. Cancer Res. 42 (1994) 127-137.
34. Nagafuchi A., Takeichi M. and Tsukita Sh.: The 102 kd cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell 65 (1991) 849-857.